Halozyme Therapeutics (HALO) Times Interest Earned (2016 - 2025)
Historic Times Interest Earned for Halozyme Therapeutics (HALO) over the last 13 years, with Q4 2025 value amounting to -$18.91.
- Halozyme Therapeutics' Times Interest Earned fell 14893.05% to -$18.91 in Q4 2025 from the same period last year, while for Dec 2025 it was $25.87, marking a year-over-year decrease of 1509.97%. This contributed to the annual value of $25.87 for FY2025, which is 1509.97% down from last year.
- Per Halozyme Therapeutics' latest filing, its Times Interest Earned stood at -$18.91 for Q4 2025, which was down 14893.05% from $50.73 recorded in Q3 2025.
- Halozyme Therapeutics' 5-year Times Interest Earned high stood at $53.11 for Q2 2021, and its period low was -$18.91 during Q4 2025.
- For the 5-year period, Halozyme Therapeutics' Times Interest Earned averaged around $26.69, with its median value being $25.87 (2021).
- Its Times Interest Earned has fluctuated over the past 5 years, first surged by 438426.38% in 2021, then tumbled by 14893.05% in 2025.
- Quarter analysis of 5 years shows Halozyme Therapeutics' Times Interest Earned stood at $27.51 in 2021, then tumbled by 40.74% to $16.3 in 2022, then increased by 18.72% to $19.36 in 2023, then soared by 99.72% to $38.66 in 2024, then tumbled by 148.93% to -$18.91 in 2025.
- Its Times Interest Earned was -$18.91 in Q4 2025, compared to $50.73 in Q3 2025 and $46.07 in Q2 2025.